DHG Pharmaceutical JSC (DHG) - Total Liabilities
Based on the latest financial reports, DHG Pharmaceutical JSC (DHG) has total liabilities worth ₫983.26 Billion VND (≈ $37.36 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore how fast is DHG Pharmaceutical JSC growing its equity to track the company's year-over-year net asset growth rate.
DHG Pharmaceutical JSC - Total Liabilities Trend (2019–2025)
This chart illustrates how DHG Pharmaceutical JSC's total liabilities have evolved over time, based on quarterly financial data. See DHG cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
DHG Pharmaceutical JSC Competitors by Total Liabilities
The table below lists competitors of DHG Pharmaceutical JSC ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Aquestive Therapeutics Inc
NASDAQ:AQST
|
USA | $175.18 Million |
|
Tengda Construction Group Co Ltd
SHG:600512
|
China | CN¥4.36 Billion |
|
ChoiceOne Financial Services Inc
NASDAQ:COFS
|
USA | $3.92 Billion |
|
Shanghai Guangdian Electric Group Co Ltd
SHG:601616
|
China | CN¥517.35 Million |
|
Compania General de Electricidad SA
SN:CGE
|
Chile | CL$2.57 Trillion |
|
Ari Real Estate Arena Investment Ltd
TA:ARIN
|
Israel | ILA2.00 Billion |
|
EUROKAI GmbH & Co. KGaA
F:EUK3
|
Germany | €317.79 Million |
|
Ranpak Holdings Corp
NYSE:PACK
|
USA | $582.60 Million |
Liability Composition Analysis (2019–2025)
This chart breaks down DHG Pharmaceutical JSC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of DHG Pharmaceutical JSC.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.29 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.24 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.19 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how DHG Pharmaceutical JSC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for DHG Pharmaceutical JSC (2019–2025)
The table below shows the annual total liabilities of DHG Pharmaceutical JSC from 2019 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ₫983.26 Billion ≈ $37.36 Million |
-47.26% |
| 2024-12-31 | ₫1.86 Trillion ≈ $70.84 Million |
+48.26% |
| 2023-12-31 | ₫1.26 Trillion ≈ $47.78 Million |
+43.45% |
| 2022-12-31 | ₫876.65 Billion ≈ $33.31 Million |
+6.32% |
| 2021-12-31 | ₫824.52 Billion ≈ $31.33 Million |
-6.25% |
| 2020-12-31 | ₫879.46 Billion ≈ $33.41 Million |
+14.32% |
| 2019-12-31 | ₫769.27 Billion ≈ $29.23 Million |
-- |
About DHG Pharmaceutical JSC
DHG Pharmaceutical Joint Stock Company, together with its subsidiaries, engages in the manufacture and sale of pharmaceutical products in Vietnam. The company offers antibiotic, analgesic and antipyretic, respiratory, nutrition, musculoskeletal, gastrointestinal and hepatobiliary, nervous and ophthalmic, cardiovascular and diabetic, and dermatology and beauty care products. It also manufactures a… Read more